Efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study

MLA

Ahmad Mirshahi, et al. “Efficacy of Adjuvant Topical Timolol–dorzolamide with Intravitreal Bevacizumab Injection in Diabetic Macular Edema: A Contralateral Eye Study.” Journal of Current Ophthalmology, vol. 31, no. 2, June 2019, pp. 168–71. EBSCOhost, https://doi.org/10.1016/j.joco.2019.01.008.

APA

Ahmad Mirshahi, Ramin Tadayoni, Navid Mohsenzadeh, Talieh Saeidi Rezvani, & Mojtaba Abrishami. (2019). Efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study. Journal of Current Ophthalmology, 31(2), 168–171. https://doi.org/10.1016/j.joco.2019.01.008

Chicago

Ahmad Mirshahi, Ramin Tadayoni, Navid Mohsenzadeh, Talieh Saeidi Rezvani, and Mojtaba Abrishami. 2019. “Efficacy of Adjuvant Topical Timolol–dorzolamide with Intravitreal Bevacizumab Injection in Diabetic Macular Edema: A Contralateral Eye Study.” Journal of Current Ophthalmology 31 (2): 168–71. doi:10.1016/j.joco.2019.01.008.